<DOC>
	<DOCNO>NCT00531544</DOCNO>
	<brief_summary>A SU011248 expand access protocol systemic therapy patient metastatic Renal Cell Carcinoma ineligible participation SU011248 protocol may derive benefit treatment SU011248</brief_summary>
	<brief_title>A SU011248 Expanded Access Protocol Systemic Therapy Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible Participation Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Patients metastatic Renal Cell Carcinoma ineligible participation SU011248 protocol may derive benefit treatment SU011248</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>